UNEXPLAINED SYMPTOMS
Your results came back normal. The answer may be in your DNA.
When blood work, imaging, and specialist visits haven't provided answers, whole genome sequencing looks where standard tests can't — across your entire genetic code — to uncover the root cause of unexplained symptoms.
What We Screen
The conditions standard tests miss.
Rare Diseases
Over 7,000 rare diseases have a genetic basis. Standard panels test for a handful. Whole genome sequencing captures them all — including conditions too rare for targeted tests.
Explore →Neurological
Complex neurological presentations — from unexplained neuropathy to movement disorders — often have a monogenic cause that standard workups miss.
Explore →Metabolic
Enzyme deficiencies and storage disorders can mimic common conditions for years. Genomic analysis identifies the underlying metabolic pathway disruption.
Explore →Autoimmune & Inflammatory
Genetic susceptibility variants can explain why autoimmune symptoms appear, persist, or fail to respond to standard therapies.
Explore →Pharmacogenomics
If medications aren't working — or cause unexpected side effects — your genome may explain why. Pharmacogenomic variants affect how you metabolize drugs.
Explore →Real Outcomes
Answers that changed lives.
RARE GENETIC SYNDROME
Two conditions from a single test
Years of specialist referrals found nothing. A single whole genome test identified Noonan Syndrome and RUNX1 deficiency, both accepted by NHS genetics.
Data accepted by NHS genetics at Queen Elizabeth University Hospital Glasgow. Clinical action taken by the NHS team. Dante produced the genomic data. This is a documented outcome at a named institution, not an endorsement by NHS.
CHILDHOOD EPILEPSY
A dietary intervention that changed everything
A 4-year-old with uncontrolled seizures. Genomic sequencing identified GLUT-1 Deficiency, shifting treatment from anticonvulsants to a ketogenic diet.
Identification of the metabolic basis allowed dietary intervention. All clinical decisions were made by the treating physicians.
NEUROLOGICAL CONDITION
A name for what no one could explain
Motor difficulties from infancy with no genetic explanation. Whole genome sequencing identified a homozygous GJC2 mutation confirming Leukodystrophy.
The genetic basis was established and a targeted care pathway developed by the clinical team.
Why Whole Genome
More than a test. A permanent health resource.
Your full DNA, not a panel
Gene panels test 50–500 genes. Whole genome sequencing reads all 20,000+ genes and the regulatory regions between them — nothing is excluded.
470+ clinical reports
Every test generates 470+ physician-ready reports covering hereditary risk, carrier status, pharmacogenomics, and more — all from a single sample.
Your test gets smarter over time
As new gene-disease associations are published, your stored genome data can be re-analysed. You sequence once and benefit from every future discovery.
The Process
Four steps to get started. No clinic visit required.
Order your kit
Free delivery worldwide.
Collect your sample
Simple finger-prick blood spot collection at home. Takes 5 minutes. Everything you need is in the kit.
Send it back
Pre-paid return label included. Drop it in any post box.
Access your results
Reports delivered to your Genome Manager in 6–8 weeks. Review every finding and share directly with your physician.
One test. A lifetime of answers.
One kit, sent to your home. Your entire genome sequenced at the clinical standard used for diagnostic decisions. 470+ physician-ready reports with Premium, delivered to your Genome Manager in 6–8 weeks — permanent and updated as science advances.
Free shipping · Results in 6–8 weeks
